Literature DB >> 3027321

[Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].

J L Raoul, R Duvauferrier, P Bourguet, J F Bretagne, S Coornaert, P Darnault, Y Deugnier, J Y Herry, J Gastard.   

Abstract

Twelve patients with hepatocellular carcinoma and cirrhosis were investigated by Lipiodol injection into the hepatic artery. A CT scan was done 4-6 days later. Lipiodol was retained by hepatic tumors in each case. This method emphasized the extension of the carcinoma and allowed to discover daughter tumors. I131-lipiodol was also injected in 4 of the 12 patients and then its biodistribution was evaluated. At the 6th hour after injection, I131-lipiodol was detected by scintigraphy over the liver (74-91 percent) and over the lungs (9-16 percent) only. The tumor to normal liver pixel count ratio was about 5. These results indicate that there is a preferential arterial blood flow towards the hepatic tumors, and that we can consider a therapeutic use of I131-Lipiodol in hepatocellular-carcinoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027321

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  5 in total

1.  Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours.

Authors:  S J Wang; W Y Lin; M N Chen; B T Hsieh; L H Shen; Z T Tsai; G Ting; F F Knapp
Journal:  Eur J Nucl Med       Date:  1996-01

2.  Hepatic intraarterial lipiodol: technique, semiologic patterns, and value for hepatic tumors.

Authors:  J N Bruneton; P Kerboul; C Grimaldi; F Normand; C Balu-Maestro; P Rampal; J Delmont
Journal:  Gastrointest Radiol       Date:  1988

3.  Preparation and biodistribution of yttrium-90 Lipiodol in rats following hepatic arterial injection.

Authors:  S J Wang; W Y Lin; M N Chen; L H Shen; Z T Tsai; G Ting
Journal:  Eur J Nucl Med       Date:  1995-03

4.  (188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside.

Authors:  Nicolas Lepareur; Valérie Ardisson; Nicolas Noiret; Etienne Garin
Journal:  Int J Mol Imaging       Date:  2012-02-22

Review 5.  Therapeutic Strategies in HCC: Radiation Modalities.

Authors:  R Gallicchio; A Nardelli; P Mainenti; A Nappi; D Capacchione; V Simeon; C Sirignano; F Abbruzzi; F Barbato; M Landriscina; G Storto
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.